{"id":"https://openalex.org/W2000927266","doi":"https://doi.org/10.1097/01.jcp.0000096247.29231.3a","title":"Chlorpromazine Equivalents Versus Defined Daily Doses: How to Compare Antipsychotic Drug Doses?","display_name":"Chlorpromazine Equivalents Versus Defined Daily Doses: How to Compare Antipsychotic Drug Doses?","alternate_titles":[],"publication_year":2003,"publication_date":"2003-11-18","ids":{"openalex":"https://openalex.org/W2000927266","doi":"https://doi.org/10.1097/01.jcp.0000096247.29231.3a","mag":"2000927266","pmid":"https://pubmed.ncbi.nlm.nih.gov/14624195"},"language":"en","primary_location":{"id":"doi:10.1097/01.jcp.0000096247.29231.3a","doi":"https://doi.org/10.1097/01.jcp.0000096247.29231.3a","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.jcp.0000096247.29231.3a","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000927266"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052418320","display_name":"Claudia A.W. Rijcken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claudia A.W. Rijcken","raw_affiliation_strings":["Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands","Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Groningen","Revised August 1, 2002 accepted after revision March 14, 2003"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Groningen","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Revised August 1, 2002 accepted after revision March 14, 2003","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089783456","display_name":"Taco B. M. Monster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Taco B.M. Monster","raw_affiliation_strings":["Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Groningen","Revised August 1, 2002 accepted after revision March 14, 2003"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Groningen","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Revised August 1, 2002 accepted after revision March 14, 2003","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075965403","display_name":"J. R. B. J. Brouwers","orcid":"https://orcid.org/0000-0002-7547-1662","observed_orcids":["https://orcid.org/0000-0002-7547-1662"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacobus R.B.J. Brouwers","raw_affiliation_strings":["Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Groningen","Revised August 1, 2002 accepted after revision March 14, 2003"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Groningen","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Revised August 1, 2002 accepted after revision March 14, 2003","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107852323","display_name":"Lolkje T.W. de Jong\u2010van den Berg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Lolkje T.W. de Jong-van den Berg","raw_affiliation_strings":["Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Groningen","Revised August 1, 2002 accepted after revision March 14, 2003","reprint requests to Lolkje T.W. de Jong-van den Berg, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. E-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Groningen","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Revised August 1, 2002 accepted after revision March 14, 2003","institution_ids":[]},{"raw_affiliation_string":"reprint requests to Lolkje T.W. de Jong-van den Berg, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I169381384"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5107852323"],"corresponding_institution_ids":["https://openalex.org/I169381384"],"apc_list":null,"apc_paid":null,"fwci":1.4837,"has_fulltext":false,"cited_by_count":128,"citation_normalized_percentile":{"value":0.80343447,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"23","issue":"6","first_page":"657","last_page":"659"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9291999936103821,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9291999936103821,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.021700000390410423,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.019099999219179153,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chlorpromazine-equivalents","display_name":"chlorpromazine equivalents","score":0.9580000042915344},{"id":"https://openalex.org/keywords/defined-daily-doses","display_name":"defined daily doses","score":0.9639999866485596},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8870000243186951},{"id":"https://openalex.org/keywords/antipsychotic-potency","display_name":"antipsychotic potency","score":0.8090000152587891},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.7459999918937683},{"id":"https://openalex.org/keywords/maintenance-dose","display_name":"maintenance dose","score":0.5590000152587891},{"id":"https://openalex.org/keywords/drug-use-evaluation","display_name":"drug use evaluation","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.8124287128448486},{"id":"https://openalex.org/C3019878999","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic drug","level":4,"score":0.7389649152755737},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.7064547538757324},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5961402058601379},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5763277411460876},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.5409785509109497},{"id":"https://openalex.org/C48921125","wikidata":"https://www.wikidata.org/wiki/Q10861030","display_name":"Linear regression","level":2,"score":0.4797138571739197},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4329657554626465},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.17223888635635376},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.1601511836051941},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.15957507491111755},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.10544320940971375}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1097/01.jcp.0000096247.29231.3a","doi":"https://doi.org/10.1097/01.jcp.0000096247.29231.3a","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.jcp.0000096247.29231.3a","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:14624195","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14624195","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Comparative Study"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/271e960e-adbf-4635-9c1f-965f164f6541","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/271e960e-adbf-4635-9c1f-965f164f6541","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rijcken, C A W, Monster, T B M, de Jong-van den Berg, L T W & Brouwers, J R B J 2003, 'Chlorpromazine equivalents versus Daily Defined Dose: How to compare antipsychotic drug doses?', Journal Clinical Psychopharmacology, vol. 23, no. 6.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/e0f1ebff-c743-4d12-ae4d-3bf8e9232c11","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/e0f1ebff-c743-4d12-ae4d-3bf8e9232c11","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rijcken, C A W, Monster, T B M, Brouwers, J R B J & de Jong-van den Berg, L T W 2003, 'Chlorpromazine equivalents versus defined daily doses : How to compare antipsychotic drug doses?', Journal of Clinical Psychopharmacology, vol. 23, no. 6, pp. 657-659. https://doi.org/10.1097/01.jcp.0000096247.29231.3a","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/271e960e-adbf-4635-9c1f-965f164f6541","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/271e960e-adbf-4635-9c1f-965f164f6541","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal Clinical Psychopharmacology, 23(6). LIPPINCOTT WILLIAMS &amp; WILKINS","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/e0f1ebff-c743-4d12-ae4d-3bf8e9232c11","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/e0f1ebff-c743-4d12-ae4d-3bf8e9232c11","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Psychopharmacology, 23(6), 657 - 659. LIPPINCOTT WILLIAMS &amp; WILKINS","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2512258217","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/chlorpromazine-equivalents-versus-daily-defined-dose-how-to-compa","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2014491795"],"related_works":["https://openalex.org/W2051026253","https://openalex.org/W2908197180","https://openalex.org/W2225494886","https://openalex.org/W2014491795","https://openalex.org/W2008138091","https://openalex.org/W2094598884","https://openalex.org/W2507950479","https://openalex.org/W2050045773","https://openalex.org/W7039134067","https://openalex.org/W2060529079"],"abstract_inverted_index":{"Classic":[0],"chlorpromazine":[1],"(CPZ)":[2],"equivalents":[3,18],"can":[4],"be":[5],"used":[6,57],"to":[7,100,157],"chart":[8],"relative":[9],"antipsychotic":[10,13,30,119,148,163],"potencies":[11,117],"of":[12,16,37,70,111,127,146,162],"drugs.":[14],"Values":[15],"CPZ":[17],"per":[19,51],"drug":[20,26,55,120,149,164],"are":[21,32],"ambiguous":[22],"in":[23,62],"literature.":[24,76],"In":[25,77],"use":[27,36],"evaluation":[28],"studies,":[29],"doses":[31],"frequently":[33],"compared":[34,121],"by":[35],"the":[38,46,71,102,106,112,128],"defined":[39],"daily":[40],"dose":[41,50],"(DDD).":[42],"The":[43,64,125],"DDD":[44,65],"is":[45,66,155],"assumed":[47],"average":[48],"maintenance":[49],"day":[52],"for":[53,58,118],"a":[54,139,159],"if":[56],"its":[59],"main":[60],"indication":[61],"adults.":[63],"based":[67],"on":[68],"review":[69],"available":[72],"older":[73],"and":[74,86,96],"recent":[75],"this":[78],"report,":[79],"we":[80,137,151],"evaluated":[81],"discrepancy":[82,141],"between":[83,105,142],"CPZ-equivalent":[84,91,123],"values":[85,92,95,114],"DDD-equivalent":[87,94,113],"values.":[88,124],"We":[89],"plotted":[90],"against":[93],"performed":[97],"linear":[98],"regression":[99,129],"determine":[101],"mean":[103],"relationship":[104],"2":[107,144],"methods.":[108],"About":[109],"67%":[110],"demonstrated":[115],"lower":[116],"with":[122],"slope":[126],"line":[130],"was":[131],"0.68":[132],"(r2":[133],"=":[134],"0.81).":[135],"Because":[136],"found":[138],"great":[140],"these":[143],"methods":[145],"comparing":[147],"doses,":[150],"think":[152],"further":[153],"research":[154],"necessary":[156],"develop":[158],"standardized":[160],"way":[161],"comparison.":[165]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000927266","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
